Surgical Science Sweden AB (publ) (FRA:4P41)

FRA:4P41 Statistics

Total Valuation

FRA:4P41 has a market cap or net worth of EUR 159.90 million. The enterprise value is 105.63 million.

Market Cap	159.90M
Enterprise Value	105.63M

Important Dates

The next estimated earnings date is Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	51.03M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.77%
Owned by Institutions (%)	45.30%
Float	43.49M

Valuation Ratios

The trailing PE ratio is 25.32 and the forward PE ratio is 13.50.

PE Ratio	25.32
Forward PE	13.50
PS Ratio	1.81
PB Ratio	0.41
P/TBV Ratio	2.08
P/FCF Ratio	30.66
P/OCF Ratio	27.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.16, with an EV/FCF ratio of 20.25.

EV / Earnings	16.72
EV / Sales	1.19
EV / EBITDA	6.16
EV / EBIT	8.82
EV / FCF	20.25

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.00.

Current Ratio	4.18
Quick Ratio	3.02
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.03
Interest Coverage	36.01

Financial Efficiency

Return on equity (ROE) is 1.60% and return on invested capital (ROIC) is 1.88%.

Return on Equity (ROE)	1.60%
Return on Assets (ROA)	1.73%
Return on Invested Capital (ROIC)	1.88%
Return on Capital Employed (ROCE)	2.96%
Revenue Per Employee	268,882
Profits Per Employee	19,256
Employee Count	274
Asset Turnover	0.21
Inventory Turnover	1.72

Taxes

In the past 12 months, FRA:4P41 has paid 2.46 million in taxes.

Income Tax	2.46M
Effective Tax Rate	28.06%

Stock Price Statistics

The stock price has decreased by -77.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-77.76%
50-Day Moving Average	7.35
200-Day Moving Average	11.40
Relative Strength Index (RSI)	16.84
Average Volume (20 Days)	139

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:4P41 had revenue of EUR 88.19 million and earned 6.32 million in profits. Earnings per share was 0.12.

Revenue	88.19M
Gross Profit	58.75M
Operating Income	11.89M
Pretax Income	8.78M
Net Income	6.32M
EBITDA	15.05M
EBIT	11.89M
Earnings Per Share (EPS)	0.12

Balance Sheet

The company has 54.03 million in cash and 146,983 in debt, giving a net cash position of 53.89 million.

Cash & Cash Equivalents	54.03M
Total Debt	146,983
Net Cash	53.89M
Net Cash Per Share	n/a
Equity (Book Value)	388.93M
Book Value Per Share	7.62
Working Capital	77.15M

Cash Flow

In the last 12 months, operating cash flow was 5.75 million and capital expenditures -534,564, giving a free cash flow of 5.22 million.

Operating Cash Flow	5.75M
Capital Expenditures	-534,564
Free Cash Flow	5.22M
FCF Per Share	n/a

Margins

Gross margin is 66.61%, with operating and profit margins of 13.48% and 7.16%.

Gross Margin	66.61%
Operating Margin	13.48%
Pretax Margin	9.96%
Profit Margin	7.16%
EBITDA Margin	17.07%
EBIT Margin	13.48%
FCF Margin	5.91%

Dividends & Yields

FRA:4P41 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	3.95%
FCF Yield	3.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:4P41 has an Altman Z-Score of 11.17 and a Piotroski F-Score of 4.

Altman Z-Score	11.17
Piotroski F-Score	4